Viridian Therapeutics, Inc./DE Interest Paid, Excluding Capitalized Interest, Operating Activities
Viridian Therapeutics, Inc./DE (VRDN) reported Interest Paid, Excluding Capitalized Interest, Operating Activities of $2.23 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:InterestPaidNet · last filed 2026-08-06
- Viridian Therapeutics, Inc./DE interest paid, excluding capitalized interest, operating activities for the quarter ending 2026-06-30 was $1.11M, a 142.45% increase year-over-year.
- Viridian Therapeutics, Inc./DE interest paid, excluding capitalized interest, operating activities for the quarter ending 2026-03-31 was $1.12M, a 149.78% increase year-over-year.
- Viridian Therapeutics, Inc./DE interest paid, excluding capitalized interest, operating activities for the quarter ending 2025-12-31 was $788.00K, a 73.95% increase year-over-year.
- Viridian Therapeutics, Inc./DE interest paid, excluding capitalized interest, operating activities for the quarter ending 2025-09-30 was $457.00K, a 0.00% change year-over-year.
- Viridian Therapeutics, Inc./DE interest paid, excluding capitalized interest, operating activities for fiscal 2025 was $2.15M, a 18.13% increase from fiscal 2024.
- Viridian Therapeutics, Inc./DE interest paid, excluding capitalized interest, operating activities for fiscal 2024 was $1.82M, a 105.42% increase from fiscal 2023.
- Viridian Therapeutics, Inc./DE interest paid, excluding capitalized interest, operating activities for fiscal 2023 was $886.00K, a 202.39% increase from fiscal 2022.
- Viridian Therapeutics, Inc./DE interest paid, excluding capitalized interest, operating activities for fiscal 2022 was $293.00K.
| Period end | Interest Paid, Excluding Capitalized Interest, Operating Activities 3 month | Interest Paid, Excluding Capitalized Interest, Operating Activities 6 month | Interest Paid, Excluding Capitalized Interest, Operating Activities 9 month | Interest Paid, Excluding Capitalized Interest, Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.23M 10-Q · filed 2026-08-06 | $3.02M derived: sum of 3 quarters · filed 2026-08-06 | $3.47M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.12M 10-Q · filed 2026-05-05 | $1.91M derived: sum of 2 quarters · filed 2026-05-05 | $2.36M derived: sum of 3 quarters · filed 2026-05-05 | $2.82M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $788.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.25M derived: sum of 2 quarters · filed 2026-02-26 | $1.70M derived: sum of 3 quarters · filed 2026-08-06 | $2.15M 10-K · filed 2026-02-26 |
| 2025-09-30 | $457.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $914.00K derived: sum of 2 quarters · filed 2026-08-06 | $1.36M 10-Q · filed 2025-11-05 | $1.81M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $457.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $905.00K 10-Q · filed 2026-08-06 | $1.36M derived: sum of 3 quarters · filed 2026-08-06 | $1.81M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $448.00K 10-Q · filed 2026-05-05 | $901.00K derived: sum of 2 quarters · filed 2026-05-05 | $1.36M derived: sum of 3 quarters · filed 2026-05-05 | $1.82M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $453.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $910.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.37M derived: sum of 3 quarters · filed 2026-02-26 | $1.82M 10-K · filed 2026-02-26 |
| 2024-09-30 | $457.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $915.00K derived: sum of 2 quarters · filed 2025-11-05 | $1.37M 10-Q · filed 2025-11-05 | $1.82M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $458.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $910.00K 10-Q · filed 2025-08-06 | $1.36M derived: sum of 3 quarters · filed 2026-02-26 | $1.57M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $452.00K 10-Q · filed 2025-05-06 | $904.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.11M derived: sum of 3 quarters · filed 2026-02-26 | $1.23M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $452.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $660.00K derived: sum of 2 quarters · filed 2026-02-26 | $774.00K derived: sum of 3 quarters · filed 2026-02-26 | $886.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $208.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $322.00K derived: sum of 2 quarters · filed 2024-11-12 | $434.00K 10-Q · filed 2024-11-12 | $583.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $114.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $226.00K 10-Q · filed 2024-08-08 | $375.00K derived: sum of 3 quarters · filed 2025-03-03 | $452.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $112.00K 10-Q · filed 2024-05-08 | $261.00K derived: sum of 2 quarters · filed 2025-03-03 | $338.00K derived: sum of 3 quarters · filed 2025-03-03 | |
| 2022-12-31 | $149.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $226.00K derived: sum of 2 quarters · filed 2025-03-03 | $293.00K 10-K · filed 2025-03-03 | |
| 2022-09-30 | $77.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $144.00K 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $67.00K 10-Q · filed 2022-08-15 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | $0.00 10-K · filed 2024-02-27 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | $69.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $0.00 10-Q · filed 2022-08-15 | $69.00K derived: sum of 3 quarters · filed 2022-08-15 | $122.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-07 | $69.00K derived: sum of 2 quarters · filed 2022-03-11 | $122.00K derived: sum of 3 quarters · filed 2022-03-11 | $206.00K derived: sum of 4 quarters · filed 2022-03-11 |
| 2020-12-31 | $69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $122.00K derived: sum of 2 quarters · filed 2022-03-11 | $206.00K derived: sum of 3 quarters · filed 2022-03-11 | $267.00K 10-K · filed 2022-03-11 |
| 2020-09-30 | $53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $137.00K derived: sum of 2 quarters · filed 2021-11-05 | $198.00K 10-Q · filed 2021-11-05 | $303.00K derived: sum of 4 quarters · filed 2021-11-05 |
| 2020-06-30 | $84.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $145.00K 10-Q · filed 2021-08-12 | $250.00K derived: sum of 3 quarters · filed 2021-08-12 | $379.00K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $61.00K 10-Q · filed 2021-05-07 | $166.00K derived: sum of 2 quarters · filed 2021-05-07 | $295.00K derived: sum of 3 quarters · filed 2021-05-07 | $436.00K derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-31 | $105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | $234.00K derived: sum of 2 quarters · filed 2021-03-26 | $375.00K derived: sum of 3 quarters · filed 2021-03-26 | $511.00K 10-K · filed 2021-03-26 |
| 2019-09-30 | $129.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $270.00K derived: sum of 2 quarters · filed 2020-11-12 | $406.00K 10-Q · filed 2020-11-12 | $537.00K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $141.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $277.00K 10-Q · filed 2020-08-05 | $408.00K derived: sum of 3 quarters · filed 2020-08-05 | $534.00K derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | $136.00K 10-Q · filed 2020-05-08 | $267.00K derived: sum of 2 quarters · filed 2020-05-08 | $393.00K derived: sum of 3 quarters · filed 2020-05-08 | $513.00K derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $131.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $257.00K derived: sum of 2 quarters · filed 2020-03-13 | $377.00K derived: sum of 3 quarters · filed 2020-03-13 | $489.00K 10-K · filed 2020-03-13 |
| 2018-09-30 | $126.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $246.00K derived: sum of 2 quarters · filed 2019-11-08 | $358.00K 10-Q · filed 2019-11-08 | $692.00K derived: sum of 4 quarters · filed 2019-11-08 |
| 2018-06-30 | $120.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $232.00K 10-Q · filed 2019-08-08 | $566.00K derived: sum of 3 quarters · filed 2019-08-08 | |
| 2018-03-31 | $112.00K 10-Q · filed 2019-05-09 | $446.00K derived: sum of 2 quarters · filed 2019-05-09 | ||
| 2017-12-31 | $334.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $446.00K 10-K · filed 2019-03-14 | ||
| 2017-09-30 | $112.00K 10-Q · filed 2018-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |